Clinical trial · Interventional
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Hydrogen Rich Water to Mitigate Acute Mucositis During Radiation Therapy
NCT05278260CI-TRIAL-00089665completedEarly Phase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mucositis Oral | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Control | Dietary Supplement | — | UNRESOLVED |
| Hydrogen tablets | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Control
- interventionNames
- Dietary Supplement: Control
- type
- EXPERIMENTAL
- label
- Active
- interventionNames
- Dietary Supplement: Hydrogen tablets
Primary outcomes (1)
- measure
- Number of participants who develop grade 3 oropharyngeal mucositis
- timeFrame
- 3 months after completing radiation therapy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor, * Planning to receive daily fractionated radiotherapy for over 4 weeks' duration * Karnofsky Performance Score (KPS) of at least 70 * Able to describe pain * Able to swallow food and water * Able to sign consent Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.